Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Aspirex Thrombectomy System

K-Number: K220270 · 2022-06-21

Decision Date2022-06-21
Product CodeQEW
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

Aspirex Thrombectomy System is a medical device manufactured by C.R. Bard, Inc.. It received FDA 510(k) clearance on 2022-06-21 under approval number K220270. The device is classified under product code QEW. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Aspirex Thrombectomy System?

Aspirex Thrombectomy System is a medical device that received FDA 510(k) clearance on 2022-06-21. It is manufactured by C.R. Bard, Inc.. The 510(k) number is K220270.

When was Aspirex Thrombectomy System approved by the FDA?

Aspirex Thrombectomy System received FDA 510(k) clearance on 2022-06-21, under approval number K220270.

What company makes Aspirex Thrombectomy System?

Aspirex Thrombectomy System is manufactured by C.R. Bard, Inc..

What is the FDA product code for Aspirex Thrombectomy System?

The FDA product code for Aspirex Thrombectomy System is QEW.

Related Clinical Trials

Other Devices by C.R. Bard, Inc.

View all 67 devices →

Related Devices (Code: QEW)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.